US FDA slaps import alert on Dabur's Silvassa plant over data integrity, sanitation lapses
The US FDA has issued an import alert on Dabur India's Silvassa facility, citing falsified records and maintenance failures. Dabur says only private-label US exports are hit, with domestic operations and overall financials unaffected — but the regulatory black mark dents the 140-year-old company's export credibility.
US FDA issued an import alert on Dabur's Silvassa plant citing data integrity and maintenance lapses, including falsified records and sanitation issues. Dabur says only private-label US exports are affected; domestic products and overall financials remain unimpacted.